These international clinical cancer research studies, conducted in partnership with the Mount Kisco Medical Group (MKMG), are contributing to the further development of IBRANCE® (palbociclib) capsules, a treatment developed and manufactured by Pfizer Inc.
To learn more about clinical trials at NWH, visit www.nwhc.net/clinicaltrials.